Novartis AG (NVS) Gets Upgraded to Overweight from Neutral by JPMorgan
Novartis AG (NYSE:NVS) is one of the best pharma stocks to invest in. On December 8, Novartis AG (NYSE:NVS) was upgraded to Overweight from Neutral by JPMorgan.
Insider Monkey Blog
J.P. Morgan Maintains a Sell Rating on GSK plc (GSK)
GSK plc (NYSE:GSK) is one of the best pharma stocks to invest in. J.P.
Argus Downgrades Novo Nordisk A/S (NVO) to Hold From Buy
Novo Nordisk A/S (NYSE:NVO) is one of the best pharma stocks to invest in. Argus analyst Jasper Hellweg downgraded Novo Nordisk A/S (NYSE:NVO) to Hold from Buy on December 8, ...
Why is AstraZeneca PLC (AZN) One of the Best Pharma Stocks to Invest In?
AstraZeneca PLC (NASDAQ:AZN) is one of the best pharma stocks to invest in. AstraZeneca PLC (NASDAQ:AZN) received a rating update from JPMorgan on December 8, with the firm lifting...
Cantor Fitzgerald Maintains a Buy Rating on Gilead Sciences (GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best pharma stocks to invest in. Cantor Fitzgerald analyst Carter Gould maintained a Buy rating on Gilead Sciences, Inc.
Jefferies Remains Bullish on Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best pharma stocks to invest in. On December 4, Jefferies reiterated a Buy rating on Bristol-Myers Squibb Company (NYSE:...
Pfizer Inc. (PFE) Announces Results from the Phase 3 BASIS Study Evaluating HYMPAVZI
Pfizer Inc. (NYSE:PFE) is one of the best pharma stocks to invest in. Pfizer Inc.
Guggenheim Lifts PT on Merck & Co. (MRK) to $122 From $104
Merck & Co., Inc. (NYSE:MRK) is one of the best pharma stocks to invest in. Guggenheim lifted the price target on Merck & Co., Inc.
Johnson & Johnson (JNJ) Announces Updated Results From the Phase 3 CARTITUDE-4 Study
Johnson & Johnson (NYSE:JNJ) is one of the best pharma stocks to invest in. Johnson & Johnson (NYSE:JNJ) announced on December 6 the updated results from the Phase 3 CARTITUDE...
Eli Lilly and Company (LLY) Announces Results From Phase 3 BRUIN CLL-314 Trial Evaluating Jaypirca Versus Imbruvica
Eli Lilly and Company (NYSE:LLY) is one of the best pharma stocks to invest in. On December 7, Eli Lilly and Company (NYSE:LLY) announced results from the Phase 3 BRUIN CLL...
12 Hot AI Stocks on Wall Street’s Radar
Global stocks slipped Wednesday as investors weighed divisions within the Federal Reserve and closely watched earnings that could test elevated valuations in the AI sector.
11 High Short Interest Stocks to Buy Right Now
On December 8, Bob Doll, Crossmark Global Investments CEO and CIO, joined CNBC’s ‘Squawk on the Street’ to discuss the latest market trends and his expectations for the ...
15 Best Stocks to Buy for the Long Term
Dividend stocks offer solid investment options when it comes to long-term investing.
Wall Street Remains Bullish On Lantheus Holdings, Inc. (LNTH)
Lantheus Holdings, Inc. (NASDAQ:LNTH) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Lantheus Holdings, Inc.
Wall Street Outlook For Elevance Health, Inc. (ELV) Supported By Prior TD Cowen Upgrade
Elevance Health, Inc. (NYSE:ELV) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Elevance Health, Inc.
Why TD Cowen Calls The Cigna Group (CI) “A Best Ideas Pick” For 2026
The Cigna Group (NYSE:CI) is among the cheap healthcare stocks to buy heading into 2026.
CVS Health Corporation (CVS) Sees Higher Price Target Despite PBM Pressures
CVS Health Corporation (NYSE:CVS) is among the cheap healthcare stocks to buy heading into 2026.
Why Wall Street Analysts Are Closely Watching Sanofi (SNY)
Sanofi (NASDAQ:SNY) is among the cheap healthcare stocks to buy heading into 2026.
Analysts See Upside In Novo Nordisk A/S (NVO) Driven By Diabetes And Obesity Trends
Novo Nordisk A/S (NYSE:NVO) is among the cheap healthcare stocks to buy heading into 2026.
Here’s Why Analysts Are Positive On Prestige Consumer Healthcare Inc. (PBH)
Prestige Consumer Healthcare Inc. (NYSE:PBH) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Prestige Consumer Healthcare Inc.
Analysts See Big Upside in Catalyst Pharmaceuticals, Inc. (CPRX)
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Catalyst Pharmaceuticals, Inc.
The Upside Story Behind Concentra Group Holdings Parent, Inc. (CON)
Concentra Group Holdings Parent, Inc. (NYSE:CON) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Concentra Group Holdings Parent, Inc.
BioMarin Pharmaceutical Inc. (BMRN) Outlook Lowered By Leerink
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is among the cheap healthcare stocks to buy heading into 2026.
Is Soleno Therapeutics, Inc. (SLNO) The Cheap Healthcare Stock To Buy Heading Into 2026?
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Soleno Therapeutics, Inc.
BMO Capital Maintains Outlook On ICON Public Limited Company (ICLR) After Management Call
ICON Public Limited Company (NASDAQ:ICLR) is among the cheap healthcare stocks to buy heading into 2026.
Analysts Adjust Price Targets for Palantir (PLTR) After Q3 Results
Palantir Technologies Inc. (NASDAQ:PLTR) is one of the 15 Best Performing AI Stocks Heading into 2026.
Massive Esports Prize Pools in 2025 — Why This Year Feels Different
The esports landscape in 2025 is anything but quiet.
Here’s Why BBH Select Series – Mid Cap Fund Decided to Sell Globant S.A. (GLOB) in Q3
Brown Brothers Harriman, an investment management company, released its Q3 2025 investor letter for the BBH Select Series - Mid Cap Fund.
Here’s Why Shift4 Payments Inc. (FOUR) Declined -21.9% in Q3
Brown Brothers Harriman, an investment management company, released its Q3 2025 investor letter for the BBH Select Series - Mid Cap Fund.
Advanced Drainage Systems (WMS) Soared as Multiple Tailwinds Align
Brown Brothers Harriman, an investment management company, released its Q3 2025 investor letter for the BBH Select Series - Mid Cap Fund.
Effective Execution and Strong Results Lifted Arista Networks (ANET) in Q3
Brown Brothers Harriman, an investment management company, released its Q3 2025 investor letter for the BBH Select Series - Mid Cap Fund.
BBH Select Series – Mid Cap Fund’s Q3 2025 Investor Letter
Brown Brothers Harriman, an investment management company, released its Q3 2025 investor letter for the BBH Select Series - Mid Cap Fund.
Pzena Focused Value Strategy Exited Its Position in Charter Communications (CHTR) in Q3
Pzena Investment Management recently released its third-quarter 2025 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here.
Here’s What Pressured Baxter International (BAX) in Q3
Pzena Investment Management recently released its third-quarter 2025 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here.
Should You Add Solventum Corp (SOLV) to Your Portfolio?
Pzena Investment Management recently released its third-quarter 2025 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here.
Do You Believe in the Growth Potential of PPG Industries (PPG)?
Pzena Investment Management recently released its third-quarter 2025 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here.
Pzena Focused Value Strategy’s Q3 2025 Investor Letter
Pzena Investment Management recently released its third-quarter 2025 commentary for “Pzena Focused Value Strategy.” Driven by optimism about AI and a September rate cut, US...
Should You Hold Centene (CNC)?
Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Mid-Cap Value Fund” third-quarter 2025 investor letter.
WPP PLC (WPP) Fell Due to Revenue Growth Falling Short of Expectations
Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Mid-Cap Value Fund” third-quarter 2025 investor letter.
Fluor Corporation (FLR) Slid on Weak Earnings Report
Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Mid-Cap Value Fund” third-quarter 2025 investor letter.
Olin Corp. (OLN) Surged Amid Challenging Environment
Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Mid-Cap Value Fund” third-quarter 2025 investor letter.
Hotchkis & Wiley Mid-Cap Value Fund’s Q3 2025 Investor Letter
Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Mid-Cap Value Fund” third-quarter 2025 investor letter.
Braze, Inc. (NASDAQ:BRZE) Q3 2026 Earnings Call Transcript
Braze, Inc. (NASDAQ:BRZE) Q3 2026 Earnings Call Transcript December 9, 2025Braze, Inc. reports earnings inline with expectations.
Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) Q3 2025 Earnings Call Transcript
Ollie's Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) Q3 2025 Earnings Call Transcript December 9, 2025Ollie's Bargain Outlet Holdings, Inc. beats earnings expectations.
SailPoint, Inc. (NASDAQ:SAIL) Q3 2026 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to SailPoint's third quarter fiscal year 2026 earnings conference call.
Designer Brands Inc. (NYSE:DBI) Q3 2025 Earnings Call Transcript
Designer Brands Inc. (NYSE:DBI) Q3 2025 Earnings Call Transcript December 9, 2025Designer Brands Inc. beats earnings expectations.
AutoZone, Inc. (NYSE:AZO) Q1 2026 Earnings Call Transcript
AutoZone, Inc. (NYSE:AZO) Q1 2026 Earnings Call Transcript December 9, 2025AutoZone, Inc. misses on earnings expectations.
Academy Sports and Outdoors, Inc. (NASDAQ:ASO) Q3 2025 Earnings Call Transcript
Academy Sports and Outdoors, Inc. (NASDAQ:ASO) Q3 2025 Earnings Call Transcript December 9, 2025Academy Sports and Outdoors, Inc. beats earnings expectations.
AeroVironment, Inc. (NASDAQ:AVAV) Q2 2026 Earnings Call Transcript
AeroVironment, Inc. (NASDAQ:AVAV) Q2 2026 Earnings Call Transcript December 9, 2025AeroVironment, Inc. misses on earnings expectations.
Cognyte Software Ltd. (NASDAQ:CGNT) Q3 2026 Earnings Call Transcript
Cognyte Software Ltd. (NASDAQ:CGNT) Q3 2026 Earnings Call Transcript December 9, 2025Cognyte Software Ltd. beats earnings expectations.
Hedge Fund Resource Center
